Recent Finacing
Recent Raise
Zynerba Pharmaceuticals develops proprietary transdermal cannabinoid delivery technologies and clinical-stage therapies, including a THC prodrug patch (ZYN001) for pain and a CBD gel (ZYN002) for epilepsy and arthritis.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor